Ian D. Dang

Array ( [id] => 7439683 [patent_doc_number] => 20040009147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Apoptosis inducing molecule II and methods of use' [patent_app_type] => new [patent_app_number] => 10/375680 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 118661 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009147.pdf [firstpage_image] =>[orig_patent_app_number] => 10375680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6706257 [patent_doc_number] => 20030152991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-14 [patent_title] => 'Eukaryotic mechanosensory transduction channel' [patent_app_type] => new [patent_app_number] => 10/369978 [patent_app_country] => US [patent_app_date] => 2003-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23131 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20030152991.pdf [firstpage_image] =>[orig_patent_app_number] => 10369978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6852005 [patent_doc_number] => 20030144208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Inhibitors for use in hemostasis and immune function' [patent_app_type] => new [patent_app_number] => 10/360186 [patent_app_country] => US [patent_app_date] => 2003-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19475 [patent_no_of_claims] => 131 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144208.pdf [firstpage_image] =>[orig_patent_app_number] => 10360186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 307238 [patent_doc_number] => 07531304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-12 [patent_title] => 'Method for screening FGFR-4 agonists' [patent_app_type] => utility [patent_app_number] => 10/503242 [patent_app_country] => US [patent_app_date] => 2003-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4737 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/531/07531304.pdf [firstpage_image] =>[orig_patent_app_number] => 10503242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206119 [patent_doc_number] => 20050043231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Therapy for growth hormone induced insulin resistance in juveniles with growth disorders' [patent_app_type] => utility [patent_app_number] => 10/499902 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9386 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043231.pdf [firstpage_image] =>[orig_patent_app_number] => 10499902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 813751 [patent_doc_number] => 07414024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-19 [patent_title] => 'Proteins with IL-6 inhibiting activity' [patent_app_type] => utility [patent_app_number] => 10/496793 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 8636 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/414/07414024.pdf [firstpage_image] =>[orig_patent_app_number] => 10496793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638963 [patent_doc_number] => 20030211994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Composition and method for modulating vasculogenesis or angiogenesis' [patent_app_type] => new [patent_app_number] => 10/303997 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 19702 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211994.pdf [firstpage_image] =>[orig_patent_app_number] => 10303997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 879971 [patent_doc_number] => 07354896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-08 [patent_title] => 'Administration of leptin' [patent_app_type] => utility [patent_app_number] => 10/286947 [patent_app_country] => US [patent_app_date] => 2002-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6311 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/354/07354896.pdf [firstpage_image] =>[orig_patent_app_number] => 10286947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872914 [patent_doc_number] => 20060165683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Methods and compositions for control of bone formation via modulation of sympathetic tone' [patent_app_type] => utility [patent_app_number] => 10/497326 [patent_app_country] => US [patent_app_date] => 2002-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 51834 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165683.pdf [firstpage_image] =>[orig_patent_app_number] => 10497326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 925797 [patent_doc_number] => 07317095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-08 [patent_title] => 'Mutant glycoproteins' [patent_app_type] => utility [patent_app_number] => 10/493540 [patent_app_country] => US [patent_app_date] => 2002-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 7002 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/317/07317095.pdf [firstpage_image] =>[orig_patent_app_number] => 10493540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7358783 [patent_doc_number] => 20040014148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein' [patent_app_type] => new [patent_app_number] => 10/197945 [patent_app_country] => US [patent_app_date] => 2002-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31673 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014148.pdf [firstpage_image] =>[orig_patent_app_number] => 10197945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851988 [patent_doc_number] => 20030144191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Polynucleotide encoding a novel TRP channel family member, TRP-PLIK2, and splice variants thereof' [patent_app_type] => new [patent_app_number] => 10/153244 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 148442 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 599 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20030144191.pdf [firstpage_image] =>[orig_patent_app_number] => 10153244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869981 [patent_doc_number] => 20030082670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Platelet-derived growth factor C, DNA coding therefor, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/131600 [patent_app_country] => US [patent_app_date] => 2002-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 24885 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082670.pdf [firstpage_image] =>[orig_patent_app_number] => 10131600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468795 [patent_doc_number] => 20040102359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Drug target within the sulfonylurea receptor' [patent_app_type] => new [patent_app_number] => 10/466313 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13625 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102359.pdf [firstpage_image] =>[orig_patent_app_number] => 10466313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905577 [patent_doc_number] => 20050100972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Use of grf1 protein for screening molecules' [patent_app_type] => utility [patent_app_number] => 10/344223 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13291 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100972.pdf [firstpage_image] =>[orig_patent_app_number] => 10344223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91678 [patent_doc_number] => 07732133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Screening methods for biologically active ligands' [patent_app_type] => utility [patent_app_number] => 10/333103 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18691 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732133.pdf [firstpage_image] =>[orig_patent_app_number] => 10333103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5637409 [patent_doc_number] => 20060068382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/824575 [patent_app_country] => US [patent_app_date] => 2001-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 166 [patent_figures_cnt] => 166 [patent_no_of_words] => 22863 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20060068382.pdf [firstpage_image] =>[orig_patent_app_number] => 09824575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535229 [patent_doc_number] => 08048855 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-11-01 [patent_title] => 'Method for suppressing graft-versus-host-disease' [patent_app_type] => utility [patent_app_number] => 10/111097 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3222 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/048/08048855.pdf [firstpage_image] =>[orig_patent_app_number] => 10111097 [rel_patent_id] =>[rel_patent_doc_number] =>)